An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment.
Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , |
---|---|
Materyal Türü: | Journal article |
Baskı/Yayın Bilgisi: |
2013
|
Özet: |
---|